Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies
Andriy Krendyukov, Christian GieffersApogenix AG, Heidelberg, GermanyCorrespondence: Andriy KrendyukovApogenix AG, Im Neuenheimer Feld 584, Heidelberg 69120, GermanyEmail andriy.krendyukov@apogenix.comAbstract: Glioblastoma is the most common and aggressive malignant tumor of the central nervous sys...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-09-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/asunercept-as-an-innovative-therapeutic-approach-for-recurrent-gliobla-peer-reviewed-article-CMAR |